SUBSCRIBE
SUBSCRIBE
News   Policy

Teva Pharmaceutical Industries Limited Sues Novartis AG, Momenta Pharmaceuticals, Inc. Over Copaxone Patent

August 29, 2008 | 
1 min read
NEW YORK (Reuters) - Teva Pharmaceutical Industries Ltd sued Swiss drugmaker Novartis AG and Momenta Pharmaceuticals Inc on Thursday, accusing them of infringing patents on its multiple sclerosis drug Copaxone.
Legal
Novartis
MORE ON THIS TOPIC
Composite contemporary collage statue of justice themis femida on the background of the target as the concept and idea of justice and law. High quality photo
Patents
Moderna Notches Much-Needed Win in COVID-19 Patent Spat With Roivant
March 4, 2026
 · 
2 min read
 · 
Tristan Manalac
Lowkey dramatic view of sun beams breaking through a dense cumulus cloudscape. Background and inspiration
Opinion
Navigating the FDA After the Storm To Advance Drug Candidates
March 3, 2026
 · 
4 min read
 · 
John Kirk
Pictured: Front view of the CDC museum in Georgia
CDC
RFK Jr. Appoints 2 New Advisors to CDC Vaccine Panel Ahead of March Meeting
March 2, 2026
 · 
2 min read
 · 
Tristan Manalac
Creative pattern made with a syringe on pastel pink background. Vaccine for Coronavirus infection. Pandemic concept.
Vaccines
Uncertainty Looms Over Pharma’s Legal Strategy as States Challenge New Vaccine Schedule
February 27, 2026
 · 
2 min read
 · 
Nick Paul Taylor